{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:26:25Z","timestamp":1761060385692,"version":"3.37.3"},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of this study was to assess the feasibility, safety and initial efficacy of paclitaxel administration using a novel drug delivery catheter for the prevention of restenosis in infrapopliteal de novo and restenotic lesions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Restenosis continues to be a great challenge after percutaneous revascularization procedures for peripheral arterial disease, particularly for below\u2010the\u2010knee applications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A prospective, multicenter first\u2010in\u2010human registry of a novel delivery catheter delivering liquid paclitaxel was conducted in 10 patients. The primary efficacy endpoint at 6 months was freedom from clinically driven target lesion revascularization (CD\u2010TLR) and the primary safety endpoint at 1, 3, and 6 months were thrombosis, major amputation in the target limb and target limb related death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All patients tolerated the procedure well with no reports of adverse procedural events. Twelve (n\u2009=\u200912) lesions in ten patients were treated with a mean lesion length of 83.3\u2009\u00b1\u200949.2 mm, with the lesion length range of 30mm to 182 mm. At 6\u2010month follow\u2010up, the rate of CD\u2010TLR was 30% (3 of 10 patients). Zero patients (0 out of 10) demonstrated thrombosis, major amputation in the target limb and target limb related death at the 1, 3, and 6 month follow\u2010up intervals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This first in\u2010human experience obtained in a multicenter study of real\u2010world de novo and restenotic lesions demonstrates a favorable safety and efficacy profile at 6 months. Randomized comparison to current drug coated balloons should be performed to further validate this approach and positive experience.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ccd.27176","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T07:34:59Z","timestamp":1500017699000},"page":"296-301","source":"Crossref","is-referenced-by-count":7,"title":["A universal drug delivery catheter for the treatment of infrapopliteal arterial disease: Results from the multi\u2010center first\u2010in\u2010human study"],"prefix":"10.1002","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-1196","authenticated-orcid":false,"given":"Frank","family":"Bunch","sequence":"first","affiliation":[{"name":"Cardiology Associates, Interventional Cardiologist and Peripheral Interventionalist, 188 Hospital Drive, Suite 100 Fairhope AL 36532"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Walker","sequence":"additional","affiliation":[{"name":"Cardiovascular Institute of the South, President and Founder, Interventional Cardiologist and Peripheral Interventionalist, 225 Dunn Street Houma LA 70360"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Kassab","sequence":"additional","affiliation":[{"name":"Michigan Outpatient Vascular Institute, Interventional Cardiologist and Peripheral Interventionalist, 5500 Auto Club Drive Dearborn MI 48126"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Carr","sequence":"additional","affiliation":[{"name":"Cardiovascular Associates of East Texas, Interventional Cardiologist and Peripheral Interventionalist, 1783 Troup Hwy Tyler TX 75701"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.113.000127"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001811"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-012-0251-4"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1223"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2006.11.008"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.RVI.0000058423.01661.57"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.05.022"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.06.1198"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.07.011"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011319.pub2"},{"key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.14797\/mdcj-9-2-103","article-title":"Endovascular techniques in limb salvage: infrapopliteal angioplasty","volume":"9","author":"Naoum JJ","year":"2013","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.avsg.2012.02.006"},{"key":"e_1_2_7_14_1","first-page":"207","article-title":"The \u201cDEBELLUM\u201d\u2013lower limb multilevel treatment with drug eluting balloon\u2013randomized trial: 1\u2010year results","volume":"55","author":"Fanelli F","year":"2014","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2014.04.015"},{"key":"e_1_2_7_16_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2016.06.036","article-title":"Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel\u2010Coated Balloons in Healthy Swine","author":"Kolodgie FD","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.2.636"},{"key":"e_1_2_7_18_1","unstructured":"GandiniR Del GiudiceC.Local Ultrasound to Enhance Paclitaxel Delivery After Femoral\u2010Popliteal Treatment in Critical Limb Ischemia: The PACUS Trial. (1876\u20137605 (Electronic))."},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.108.827865.108.827865"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706356"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.27176","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.27176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T07:37:05Z","timestamp":1695713825000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.27176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1002\/ccd.27176"],"URL":"https:\/\/doi.org\/10.1002\/ccd.27176","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"type":"print","value":"1522-1946"},{"type":"electronic","value":"1522-726X"}],"subject":[],"published":{"date-parts":[[2017,7,14]]}}}